Researchers from University of Utah Report Recent Findings in Acute Lymphoblastic Leukemia [Contributions of Pediatric Hematology/oncology To the Diagnosis, Treatment, and Cure of Acute Lymphoblastic Leukemia: Part 2a (Numbers 11 To 15)].

Researchers from the University of Utah have made significant contributions to the diagnosis and treatment of Acute Lymphoblastic Leukemia (ALL), a common pediatric malignancy. Their work has led to high complete response rates, long-term remissions, and probable cure in a majority of patients. The research highlights advancements in understanding the causes of ALL, pediatric-inspired treatment trials, L-asparaginase, chimeric antigen receptor T-cell therapy, and aggressive multiagent therapy for high-risk ALL. The study emphasizes the progress made in pediatric hematology/oncology and its positive impact on patient outcomes. [Extracted from the article]